The Synaptic Bases of Mental Diseases
14 May 2019
Synapsy researcher Claudia Bagni, Professor of Neuroscience and Head of the Department of Basic Neurosciences at the University of Lausanne, publishes a review on synaptopathies in the journal Neuron with her colleague Suzanne Zukins from the Albert Einstein College of Read more…
19 December 2018
Eleonora Rosina Highlight from the Bagni’s Lab Genes encoding for proteins involved in synaptic protein synthesis seem to contribute to the development of Autism Spectrum Disorders. They are now suspected as early biomarkers. Eleonora Rosina, a PhD student in Read more…
18 December 2018
A new Synapsy era has emerged with the entering in Phase-3. Its success will depend, among other things, on Synapsy’s ability to transfer technologies. It didn’t take long to hear about a great example of technology transfer! Last October, the Read more…
Eye-tracking experience Each dot indicates the position of the gaze while viewing a video showing a child playing. Left : the blue dots are the areas targeted by a child with typical cerebral development. Right : the red dots are targeted by Read more…
1 March 2018
Each dot represents the gaze position for an individual child watching the movie. The blue dots on the left represent the typically developing toddlers. The red dots represent toddlers with Autism Spectrum Disorders (ASD). The face wasn’t blurred during the Read more…
13 October 2016
The diagnosis of Autistic Spectrum Disorders (ASD) is based on behavioral observations. It is hard to make such a diagnosis for sure before the age of 3. However, the first years of life are a period marked by a great Read more…
7 January 2015
The Federation of European Neuroscience Societies (FENS) and the Kavli Foundation have selected 20 young European neuroscience researchers for the excellence of their research. NCCR-Synapsy is very proud to announce that Professors Camilla Bellone and Johannes Gräff are among the Read more…
22 December 2014
Professor Draganski’s team analysed brains from people at risk of developing autism spectrum disorder and schizophrenia. This led to the discovery of a potential biomarker for preclinical use. Autism spectrum disorder, schizophrenia and obesity all have in common a ‘bad’ Read more…
